Of note, at late AD stages (BS5/6), the AT8 signal was detected in all tissues as expected, and the total H3K9me3 fluorescence was significantly reduced, further supporting our evidence regarding the Tau-dependent alteration of heterochromatin (Figures 5A,B). Here, MAPT is linked to Alzheimer disease.